[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Patients in dexamethasone group receive intravenous dexamethasone (manufactured by Abouraihan Pharmaceutical Company) at dose of 20 mg/day for day's one to five and then 10 mg/day for day's 6 to 10. Also patients receive supportive treatments including oxygen therapy and fluid therapy. According to the national guideline, patients receive Lopinavir/ritonavir tablets (Hetered Pharmaceutical Company, India) at dose of 200/50 mg in two tablets per day.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: Patients receive supportive treatments including oxygen therapy and fluid therapy. Also, according to the national guideline, patients receive Lopinavir/ritonavir tablets (Hetered Pharmaceutical Company, India) at dose of 200/50 mg in two tablets per day.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 400, "treatment_name": "Dexamethasone", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]